Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|December 15, 2025
Targeting RUNX1 Germline Variants: Agents Under InvestigationSaman Ghalamkari, Christopher N Hahn, Amelia Lau, et al.
Molecular Cancer Therapeutics|October 29, 2014
Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic responseRachel E Rempel, Xiaolei Jiang, Paul Fullerton, et al.
Plos One|March 21, 2015
Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics studyLing-Zhi Wang, Sok-Hwei Goh, Andrea Li-Ann Wong, et al.
Journal of Mass Spectrometry : JMS|March 16, 2013
Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryLing-Zhi Wang, Win-Lwin Thuya, Dorothy Su-Lin Toh, et al.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
Plos One|February 6, 2013
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patientsLing-Zhi Wang, Jacqueline Ramírez, Winnie Yeo, et al.
Aesthetic Surgery Journal|August 12, 2025
Tranexamic Acid and the Risk of Hematoma and Seroma Following Implant-Based Breast Reconstruction: A Retrospective Study of 1782 PatientsCaroline Barskov Norlin, Tim Kongsmark Weltz, Erik Eiler Frydshou Bak, et al.
EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.
Nature Communications|May 1, 2020
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationLi Ren Kong, Richard Weijie Ong, Tuan Zea Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal CarcinomaWan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha, et al.
Pageof 2